盐酸氨溴索在COPD合并肺部感染患者中的应用效果#br#

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (38 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo investigate the effect of Ambroxol hydrochloride in patients with COPD complicated with pulmonary infection.Methods112 patients with COPD complicated with pulmonary infection in our hospital from September 2013 to September 2016 were randomly divided into observation group and control group，each group with 56 cases.Patients in the control group were treated by conventional symptomatic treatment,patients in the observation group were treated with ambroxol hydrochloride on the basis of routine treatment.The therapeutic effects and adverse reactions of the two groups were observed and compared.ResultsThe total efficiency of the observation group was 91.1%，significantly higher than the control group(78.6%)，the difference was statistically significant(P＜0.05).After treatment，CPIS score of patients in the two groups was significantly decreased compared with before treatment，and the CPIS score of treatment group was significantly lower than that of the control group，the clinical symptoms improved time and hospitalization time of patients in the observation group were significantly shorter than those of the control group，the differences were statistically significant(P＜0.05).There was no significant difference in adverse reactions between the two groups（P＞0.05）.ConclusionAmbroxol hydrochloride has significant curative effect in patients with COPD combined with pulmonary infection，can effectively improve the clinical symptoms of patients，promote the early recovery of patients，with less adverse reactions and safety，and has a high clinical value.

Key words： Ambroxol Chronic obstructive pulmonary disease Pulmonary infection Curative effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHEN Lu

Cite this article:

SHEN Lu. Study on the effect of Ambroxol hydrochloride in patients with COPD complicated with pulmonary infection[J]. 中国当代医药, 2017, 24(15): 28-30.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I15/28

[1]	樊彩云，刘向文.盐酸氨溴索治疗慢阻肺并急性肺部感染的临床疗效观察[J].内蒙古中医药，2014，33（6）：88-89.
[2]	Li JQ.Ipratropium Bromide combined with Terbutaline Sulphate Aerosol inhalation treatment in elderly patients with chronic obstructive pulmonary disease observation[J].Chin J Clini Rattional Drug Use，2013，6（36）：652-657.
[3]	刘新艳.注射用盐酸氨溴索对慢性阻塞性肺疾病急性加重期患者肺功能的影响[J].河北中医，2013，35（7）：1103-1105.
[4]	付会文，许运铎，孙涛，等.无创正压通气对AECOPD合并肺心病患者血气分析、血浆高敏C反应蛋白和N-末端脑钠肽前体的影响[J].疑难病杂志，2014（6）：590-591，596.
[5]	王海娟，吴涛，田桂珍，等.胸腺肽联合阿奇霉素治疗老年COPD继发肺部感染疗效及对肺功能和血气指标的影响[J].疑难病杂志，2016，15（3）：225-228.
[6]	孙勉，张幸.盐酸氨溴索对COPD发作期并发肺部感染的疗效观察[J].临床肺科杂志，2014，19（8）：1511-1513.
[7]	刘博，张睿，彭伟，等.盐酸氨溴索辅助治疗对慢性阻塞性肺疾病伴肺部感染患者肺功能和血气指标的影响 [J].疑难病杂志，2016，15（10）：1020-1023.
[8]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南（2013年修订版）[J].中华结核和呼吸杂志，2013，36（4）：255-264.
[9]	Meng X，Wang C，Cao D，et al.Short-term effect of ambient air pollution on COPD mortality in four Chinese cities[J]. Atmos Environ，2013，77（7）：149-154.
[10]	蒋永均.盐酸氨溴索治疗老年慢阻肺合并肺感染的临床观察[J].中国老年保健医学，2014，17（5）：177-178.
[11]	Jiang YJ.Clinical observation on ambroxol hydrochloride in treatment of chronic obstructive pulmonary disease combined pulmonary infections[J].Chin J Geriatr Care，2014（5）：1175-1179.
[12]	郑文旭，张保朝，卢万里，等.盐酸氨溴索治疗昏迷患者肺部感染的临床研究[J].中华医院感染学杂志，2014，24（14）：3495-3496，3520.
[13]	王莹，蒋晗，杨炜.盐酸氨溴索治疗老年性肺部感染的疗效观察[J].现代临床医学，2010，36（1）：321-322.
[14]	陈元姝.盐酸氨溴索治疗急性发作期慢性阻塞性肺疾病效果研究[J].当代医学，2014，20（16）：241-242.
[15]	梁旭满，黄干.慢阻肺合并肺部感染患者应用盐酸氨溴索和对症治疗的疗效观察[J].中国医学创新，2015，12（35）：19-22.
[16]	朱勇.滋补肺肾法在老年性肺炎患者中的应用[J].西部中医药，2015，28（5）：100-102.